Atul Malhotra, MD
Sleep Medicine · San Diego, CANPI 1982695169
Payments from drug & device makers
Across 231 payments — averaging $6218.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Products Limited$579K
- Resmed Corp$201K
- Livanova USA, Inc.$189K
- Eli Lilly$173K
- Jazz Pharmaceuticals Inc.$76K
- ZOLL Respicardia, Inc.$62K
- plus $155K from 17 others
Across 1 payment — averaging $32,706 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$33K
What the payments were for
- Consulting fees$651,81285%
- Speaking & faculty fees$86,77911%
- Travel & lodging$24,2483%
- Food & beverage$8,2581%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Products Limited | 13 | $579,180 |
| Resmed Corp | 17 | $201,035 |
| Livanova USA, Inc. | 29 | $188,668 |
| Eli Lilly | 46 | $173,403 |
| Jazz Pharmaceuticals Inc. | 23 | $76,499 |
| ZOLL Respicardia, Inc. | 17 | $62,103 |
| Itamar Medical Inc | 7 | $60,095 |
| Powell Mansfield Inc | 2 | $28,000 |
| Aerin Medical Inc. | 5 | $22,752 |
| Merck | 23 | $22,332 |
| Novo Nordisk | 2 | $6,550 |
| Boehringer Ingelheim International GmbH | 12 | $6,173 |
| Eisai Inc. | 12 | $5,041 |
| Harmony Biosciences LLC | 5 | $1,698 |
| Rigel Pharmaceuticals, Inc. | 1 | $1,200 |
| ZOLL Medical Corporation | 1 | $508 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $453 |
| Impulse Dynamics (USA) Inc. | 1 | $178 |
| Lilly USA, LLC | 2 | $148 |
| Roche Molecular Systems, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 3 | $111 |
| Alkermes, Inc. | 2 | $63 |
| Abbott | 1 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THN Sleep Therapy$183,587
- SUNOSI$73,591
- AirSense$63,440
- remede System$61,861
- AIR 11$55,640
- WatchPat$36,000
- WatchPATONE$24,080
- VIVAER STYLUS$22,679
- XYREM$7,800
- Dayvigo$4,762
- XYWAV$1,956
- Wakix$1,588
- Tavalisse$1,200
- OPTIMIZER$355
- LUMRYZ$131
- RHINAER STYLUS$125
- ZEPBOUND$123
How this compares
$1,436,368 in reported general payments places this provider in the 95th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 23 | $78 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in San Diego
- Lisa ShivesSan Diego$1.4M
- Robert OwensSan Diego$43K
- Pegah MashayekhiSan Diego$25K
- Emmanuel MignotStanford$4.7M
- Daniel NormanLos Angeles$4.2M
- Haramandeep SinghSan Ramon$1.3M
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Clete KushidaStanford$231K
- Sam KashaniSanta Monica$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.